SUBSCRIBERS

Vickers Venture SPAC to merge with subsidiary of Sorrento Therapeutics

Michelle Zhu
Published Fri, Mar 18, 2022 · 09:50 PM

    Singapore

    VICKERS Venture Partners' Nasdaq-listed special purpose acquisition company (SPAC) Vickers Vantage Corp I is merging with Scilex Holding Company, a commercial biopharmaceutical company focused on developing and commercialising non-opioid therapies for patients with acute and chronic pain.

    Scilex Holding is a subsidiary of pharma giant Sorrento Therapeutics, which is also listed on the Nasdaq.

    Copyright SPH Media. All rights reserved.